Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Evolving Neuroimaging Findings during COVID-19

Evolving Neuroimaging Findings during COVID-19 EDITORIAL these patients are at a very high thrombotic risk. At this point, Evolving Neuroimaging Findings the use of therapeutic or prophylactic anticoagulation started to during COVID-19 increase for hospitalized patients. For clinical neuroradiologists, more brain imaging demonstrated hemorrhagic strokes, whether R. Jain hemorrhagic conversion of ischemic stroke or parenchymal hem- orrhages, of which many were in patients receiving therapeutic or prophylactic anticoagulation. Hemorrhagic stroke constituted about 25% of positive neuroimaging findings during this early 1,6 he coronavirus 2019 (COVID-19) pandemic first appeared and midphase of the pandemic. Tin the United States in late February, and New York City Neuroradiologists have seen their share of various zoonotic vi- (NYC) had its first case on March 1, 2020, with the outbreak ral outbreaks affecting the central nervous system in the past few reaching its peak in NYC around April 7. NYC hospitals started decades. Neurologic injury in COVID-19 is hypothesized to be to see a surge of patients with COVID-19 during the early pan- due to 2 mechanisms: 1) direct virus injury; and 2) indirect demic epoch, which quickly saturated the health care resources. injury–related cytokine storm and increased coagulation. There During the early pandemic epoch, most patients were treated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Neuroradiology American Journal of Neuroradiology

Evolving Neuroimaging Findings during COVID-19

American Journal of Neuroradiology , Volume 41 (8) – Aug 1, 2020

Loading next page...
 
/lp/american-journal-of-neuroradiology/evolving-neuroimaging-findings-during-covid-19-XDRNCFHPaA
Publisher
American Journal of Neuroradiology
Copyright
© 2020 by American Journal of Neuroradiology. Indicates open access to non-subscribers at www.ajnr.org
ISSN
0195-6108
eISSN
1936-959X
DOI
10.3174/ajnr.A6658
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL these patients are at a very high thrombotic risk. At this point, Evolving Neuroimaging Findings the use of therapeutic or prophylactic anticoagulation started to during COVID-19 increase for hospitalized patients. For clinical neuroradiologists, more brain imaging demonstrated hemorrhagic strokes, whether R. Jain hemorrhagic conversion of ischemic stroke or parenchymal hem- orrhages, of which many were in patients receiving therapeutic or prophylactic anticoagulation. Hemorrhagic stroke constituted about 25% of positive neuroimaging findings during this early 1,6 he coronavirus 2019 (COVID-19) pandemic first appeared and midphase of the pandemic. Tin the United States in late February, and New York City Neuroradiologists have seen their share of various zoonotic vi- (NYC) had its first case on March 1, 2020, with the outbreak ral outbreaks affecting the central nervous system in the past few reaching its peak in NYC around April 7. NYC hospitals started decades. Neurologic injury in COVID-19 is hypothesized to be to see a surge of patients with COVID-19 during the early pan- due to 2 mechanisms: 1) direct virus injury; and 2) indirect demic epoch, which quickly saturated the health care resources. injury–related cytokine storm and increased coagulation. There During the early pandemic epoch, most patients were treated

Journal

American Journal of NeuroradiologyAmerican Journal of Neuroradiology

Published: Aug 1, 2020

There are no references for this article.